EUVIMED · CrossrefJournal
Human Gene Therapy
ISSN 1043-0342 · SAGE Publications
Latest articles
Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy
Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer’s Disease High-Risk APOE4 Variant and Replace with Protective APOE2
Engineering Human Hematopoietic Stem and Progenitor Cells for Antigen Expression in Antigen-Presenting Cells
InsightRP2—An Interdisciplinary Approach Toward Therapy Development in RP2 -Associated Retinopathy
Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy
Automated Production of Gene-Edited CAR-T Cells for People Living with HIV
Beyond Viruses: Transposons and CRISPR-Programmable Nonviral Systems for Genome Engineering
Food and Drug Administration Grants Ultragenyx’s Fayuvi™ First-Ever Approval for Sanfilippo Syndrome Type A Treatment
The preCDD Network as a Model for Academic Preclinical Cancer Drug Development in Germany
Killers by Design: How Innovative Gene-Engineering Fine-Tunes NK Cells as Next Generation Immunotherapies
Recombinant AAV-Based Gene Therapy for Central Nervous System Disorders: From Gene Replacement to Precision Editing and Circuit Modulation
An Investigation on the Association Between HIV-1 Integrase and Gene Knock-out
AAV6 Preferentially Transduces Human Choroid Plexus Epithelium in Cerebrospinal Fluid
Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases
Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective
Physiologically Regulated Frataxin Gene Replacement Restores Neurological Function in a Mouse Model of Friedreich Ataxia
Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects
Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors
A Modular Polymer Enhancer Promotes AAV Transduction and Circumvents Preexisting Immunity in Nonhuman Primates
Monitoring Fetal Somatic Cell Genome Editing In Vivo with Total-Body Positron Emission Tomography: Studies in Rhesus Macaques ( Macaca mulatta )
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study
Harvest Process and Affinity Resin Selection Impacts on Adeno-Associated Virus Residual Host Cell Protein Retention
Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors
Strategies and Advances in Site-Specific Integration of Exogenous Large Genes
The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis
Regeneron Wins FDA Approval for First Neurosensory Gene Therapy
Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”
6 TH International Conference on Lymphocyte Engineering 15–17 July 2026 Milan, Italy
6 TH International Conference on Lymphocyte Engineering Author Index
Prime Editing of Alzheimer’s Disease High-Risk APOE4 Allele by Brain-Directed Adeno-Associated Virus Vectors
Volumes
2026 · 1232025 · 982024 · 952023 · 1312022 · 1402021 · 1602020 · 1592019 · 1442018 · 1412017 · 1222016 · 1112015 · 962014 · 1382013 · 1142012 · 1472011 · 1852010 · 1592009 · 1822008 · 2222007 · 1222006 · 2492005 · 2422004 · 1452003 · 1702002 · 2022001 · 2002000 · 2261999 · 2991998 · 3081997 · 2251996 · 2211995 · 1681994 · 1701993 · 1071992 · 881991 · 571990 · 55
EUVIMED